Newsletter Vol. 7 In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry. Watch The Vid...
American Gene Technologies International Inc. (AGT)
A private biotechnology company developing cures and treatments
for Infectious diseases, cancers and monogenic disorders.
AGT, has a broad, robust lentiviral delivery platform evolved over ten years of advanced development. AGT has an extensive and growing patent portfolio surrounding its lentiviral platform innovations that accelerate the development of a wide variety of drug candidates. This platform allows AGT to pursue exciting clinical “cures” in large and orphan indications and complex diseases. AGT’s proprietary platform technologies provide reusable components that allow AGT and its internationally recognized collaborators to create new therapies in a fraction of the time of traditional drug development processes and other drug companies. AGT will begin clinical trials this year for an HIV cure based on a successful pre-IND meeting with FDA in October of 2016.
Latest AGT Tweets
Thank you for sharing this @synpromics and thank you @alliancerm for a wonderful event #CGDay19. We have a lot to get excited about as the cell and #genetherapy industry has a bright future ahead! https://t.co/zrPMwU3udk
AGT has been granted a fifth patent by @uspto protecting its #immunotherapy #cancer #cure asset. The patent adds protection to @AmericanGene’s proprietary methods to successfully attack a variety of solid tumors. Read more: https://t.co/m54AVsWkTb #mdBioHealth https://t.co/gDi4DPKB4a
Don't Miss Out on these featured sessions focusing on the Advancing Science and Accelerating Innovation in the #BioHealthCapitalRegion on April 8th-9th! Register Today > https://t.co/rqj9J7JCIE @americangene @BioHealthInnov @BioHealthCR @MDTechCouncil @MDBiz https://t.co/4kBSNfl2c5